Yarrow Bioscience, Inc.
PrivateLast Round
Series A
Dec 18, 2025
Total Funding Raised
$100M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Yarrow Bioscience, Inc. is a biotechnology company focused on developing transformative therapies for autoimmune thyroid diseases, including Graves' disease and thyroid eye disease.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Yarrow Bioscience, Inc. Comparables
Compare Yarrow Bioscience, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AV7 Limited | 90% | |
| Ollin Biosciences | 80% | |
| Regeneron Pharmaceuticals | 80% |
Yarrow Bioscience, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Dec 18, 2025 | ||||
| Series A | Dec 17, 2025 |
Yarrow Bioscience, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Janus Henderson Group | Series A |
| LifeSci Venture Partners | Series A |
| Perceptive Advisors | Series A |
| OrbiMed | Series A |
| Logos Capital | Series A |
| venBio | Series A |
| RTW Investments | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 18, 2025
$100M round led by RTW Investments and OrbiMed.
- Dec 17, 2025
$200M round led by RTW Investments and OrbiMed.
Recent news
Latest coverage and updates
- has_revenueSep 13, 2026
Yarrow Bioscience, Inc. has revenue of $100K.
- receives_financingSep 11, 2026
Yarrow Bioscience, Inc. received financing of $150M in underwritten public offering on Sep 11th '26.
- receives_financingJul 29, 2026
Yarrow Bioscience, Inc. received financing of $5.9M in Series A on Jul 29th '26.
Yarrow Bioscience, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Yarrow Bioscience, Inc.'s valuation, stock price, and market status.
Is Yarrow Bioscience, Inc. a public or private company?
Yarrow Bioscience, Inc. is a private company.
What is the current stock price of Yarrow Bioscience, Inc.?
Yarrow Bioscience, Inc. is a private company with no public stock price. Caplight tracks Yarrow Bioscience, Inc.'s secondary market activity and provides MarketPrice estimates to Caplight users.
How much is Yarrow Bioscience, Inc. worth (valuation)?
Valuation information for Yarrow Bioscience, Inc. is not publicly available.
Can I buy Yarrow Bioscience, Inc. stock?
Yarrow Bioscience, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Yarrow Bioscience, Inc.'s last funding round?
Yarrow Bioscience, Inc.'s most recent funding round was Series A on December 18, 2025.
Who are the main investors in Yarrow Bioscience, Inc.?
Key investors in Yarrow Bioscience, Inc. include OrbiMed, RTW Investments.
Will Yarrow Bioscience, Inc. IPO soon?
No public IPO plans have been announced for Yarrow Bioscience, Inc..
How can I track Yarrow Bioscience, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Yarrow Bioscience, Inc.'s secondary market activity and sign up for updates.